Literature DB >> 11420495

Re: Stapfer M et al. Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy. Ann Surg 2000; 232:191-8.

T J Howard.   

Abstract

Mesh:

Year:  2001        PMID: 11420495      PMCID: PMC1421958          DOI: 10.1097/00000658-200107000-00027

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  6 in total

1.  Significance of retroperitoneal air after endoscopic retrograde cholangiopancreatography with sphincterotomy.

Authors:  J L Genzlinger; M S McPhee; J K Fisher; K M Jacob; J H Helzberg
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

2.  Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy.

Authors:  M Stapfer; R R Selby; S C Stain; N Katkhouda; D Parekh; N Jabbour; D Garry
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

Review 3.  Endoscopic sphincterotomy complications and their management: an attempt at consensus.

Authors:  P B Cotton; G Lehman; J Vennes; J E Geenen; R C Russell; W C Meyers; C Liguory; N Nickl
Journal:  Gastrointest Endosc       Date:  1991 May-Jun       Impact factor: 9.427

4.  Retroperitoneal perforations following endoscopic sphincterotomy; clinical course and management.

Authors:  F Dunham; N Bourgeois; M Gelin; J Jeanmart; J Toussaint; M Cremer
Journal:  Endoscopy       Date:  1982-05       Impact factor: 10.093

5.  Classification and management of perforations complicating endoscopic sphincterotomy.

Authors:  T J Howard; T Tan; G A Lehman; S Sherman; J A Madura; E Fogel; M L Swack; K K Kopecky
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

6.  CT before and after ERCP: detection of pancreatic pseudotumor, asymptomatic retroperitoneal perforation, and duodenal diverticulum.

Authors:  J H de Vries; L E Duijm; W Dekker; G L Guit; J Ferwerda; E T Scholten
Journal:  Gastrointest Endosc       Date:  1997-03       Impact factor: 9.427

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.